{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:59:50Z","timestamp":1791604790228,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00392-023-02348-4","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T16:03:04Z","timestamp":1702569784000},"page":"469-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Multi-parametric non-contrast cardiac magnetic resonance for the differentiation between cardiac amyloidosis and hypertrophic cardiomyopathy"],"prefix":"10.1007","volume":"113","author":[{"given":"Henning","family":"Steen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Montenbruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Kallifatidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6038-2253","authenticated-orcid":false,"given":"Grigorios","family":"Korosoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"issue":"7","key":"2348_CR1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/CIRCRESAHA.117.309711","volume":"121","author":"WJ McKenna","year":"2017","unstructured":"McKenna WJ, Maron BJ, Thiene G (2017) Classification, Epidemiology, and Global Burden of Cardiomyopathies. Circ Res 121(7):722\u2013730","journal-title":"Circ Res"},{"key":"2348_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2147\/VHRM.S295376","volume":"17","author":"G Korosoglou","year":"2021","unstructured":"Korosoglou G, Giusca S, Andre F et al (2021) Diagnostic work-up of cardiac amyloidosis using cardiovascular imaging: current standards and practical algorithms. Vasc Health Risk Manag 17:661\u2013673","journal-title":"Vasc Health Risk Manag"},{"issue":"3988","key":"2348_CR3","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1126\/science.172.3988.1150","volume":"172","author":"GG Glenner","year":"1971","unstructured":"Glenner GG, Terry W, Harada M, Isersky C, Page D (1971) Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science 172(3988):1150\u20131151","journal-title":"Science"},{"key":"2348_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijcard.2019.07.051","volume":"300","author":"N Maurizi","year":"2020","unstructured":"Maurizi N, Rella V, Fumagalli C et al (2020) Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy. Int J Cardiol 300:191\u2013195","journal-title":"Int J Cardiol"},{"issue":"3","key":"2348_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00392-022-02114-y","volume":"112","author":"S Ney","year":"2023","unstructured":"Ney S, Ihle P, Ruhnke T et al (2023) Epidemiology of cardiac amyloidosis in Germany: a retrospective analysis from 2009 to 2018. Clin Res Cardiol 112(3):401\u2013408","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"2348_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00392-022-02035-w","volume":"112","author":"B Chamling","year":"2023","unstructured":"Chamling B, Bietenbeck M, Korthals D et al (2023) Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging. Clin Res Cardiol 112(3):353\u2013362","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"2348_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1161\/CIRCRESAHA.116.307974","volume":"119","author":"VO Puntmann","year":"2016","unstructured":"Puntmann VO, Peker E, Chandrashekhar Y, Nagel E (2016) T1 Mapping in characterizing myocardial disease: a comprehensive review. Circ Res 119(2):277\u2013299","journal-title":"Circ Res"},{"key":"2348_CR8","doi-asserted-by":"crossref","unstructured":"Korosoglou G, Giusca S, Gitsioudis G, Erbel C, Katus HA (2014) Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification. Front Physiol 5: 291.","DOI":"10.3389\/fphys.2014.00291"},{"issue":"1","key":"2348_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12968-021-00775-8","volume":"23","author":"S Giusca","year":"2021","unstructured":"Giusca S, Steen H, Montenbruck M et al (2021) Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance. J Cardiovasc Magn Reson 23(1):92","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"2348_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/ndt\/gfs492","volume":"28","author":"W Tang","year":"2013","unstructured":"Tang W, McDonald SP, Hawley CM et al (2013) End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases. Nephrol Dial Transplant 28(2):455\u2013461","journal-title":"Nephrol Dial Transplant"},{"issue":"19","key":"2348_CR11","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","volume":"98","author":"D Phelan","year":"2012","unstructured":"Phelan D, Collier P, Thavendiranathan P et al (2012) Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98(19):1442\u20131448","journal-title":"Heart"},{"issue":"6","key":"2348_CR12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1161\/CIRCIMAGING.113.000683","volume":"6","author":"D Liu","year":"2013","unstructured":"Liu D, Hu K, Niemann M et al (2013) Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. Circ Cardiovasc Imaging 6(6):1066\u20131072","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"2348_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","volume":"64","author":"BJ Maron","year":"2014","unstructured":"Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS (2014) Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol 64(1):83\u201399","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2348_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"MA Gertz","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH et al (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004. Am J Hematol 79(4):319\u2013328","journal-title":"Am J Hematol"},{"issue":"2","key":"2348_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/HJR.0b013e3283347fdb","volume":"17","author":"NH Prakken","year":"2010","unstructured":"Prakken NH, Velthuis BK, Teske AJ, Mosterd A, Mali WP, Cramer MJ (2010) Cardiac MRI reference values for athletes and nonathletes corrected for body surface area, training hours\/week and sex. Eur J Cardiovasc Prev Rehabil 17(2):198\u2013203","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"4","key":"2348_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00392-020-01799-3","volume":"110","author":"A Yilmaz","year":"2021","unstructured":"Yilmaz A, Bauersachs J, Bengel F et al (2021) Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK). Clin Res Cardiol 110(4):479\u2013506","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"2348_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the society for cardiovascular magnetic resonance (SCMR) endorsed by the European association for cardiovascular imaging (EACVI). J Cardiovasc Magn Reson 19(1):75","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"2348_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/ehjci\/jeu291","volume":"16","author":"N Cardim","year":"2015","unstructured":"Cardim N, Galderisi M, Edvardsen T et al (2015) Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging 16(3):280","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"2348_CR19","doi-asserted-by":"publisher","first-page":"14100","DOI":"10.1038\/s41598-018-32226-3","volume":"8","author":"S Giusca","year":"2018","unstructured":"Giusca S, Korosoglou G, Zieschang V et al (2018) Reproducibility study on myocardial strain assessment using fast-SENC cardiac magnetic resonance imaging. Sci Rep 8(1):14100","journal-title":"Sci Rep"},{"issue":"4","key":"2348_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ehf2.12442","volume":"6","author":"G Korosoglou","year":"2019","unstructured":"Korosoglou G, Giusca S, Hofmann NP et al (2019) Strain-encoded magnetic resonance: a method for the assessment of myocardial deformation. ESC Heart Fail 6(4):584\u2013602","journal-title":"ESC Heart Fail"},{"issue":"1","key":"2348_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12968-021-00711-w","volume":"23","author":"H Steen","year":"2021","unstructured":"Steen H, Giusca S, Montenbruck M et al (2021) Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis. J Cardiovasc Magn Reson 23(1):45","journal-title":"J Cardiovasc Magn Reson"},{"issue":"6","key":"2348_CR22","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jcmg.2020.10.024","volume":"14","author":"G Korosoglou","year":"2021","unstructured":"Korosoglou G, Giusca S, Montenbruck M et al (2021) Fast Strain-Encoded Cardiac Magnetic Resonance for Diagnostic Classification and Risk Stratification of Heart Failure Patients. JACC Cardiovasc Imaging 14(6):1177\u20131188","journal-title":"JACC Cardiovasc Imaging"},{"key":"2348_CR23","doi-asserted-by":"crossref","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V, et al. (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the american heart association. Circulation 105(4): 539\u201342.","DOI":"10.1161\/hc0402.102975"},{"issue":"1","key":"2348_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12968-017-0376-0","volume":"19","author":"LK Williams","year":"2017","unstructured":"Williams LK, Forero JF, Popovic ZB et al (2017) Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics. J Cardiovasc Magn Reson 19(1):61","journal-title":"J Cardiovasc Magn Reson"},{"issue":"7 Pt 1","key":"2348_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jcmg.2018.06.016","volume":"12","author":"PE Bravo","year":"2019","unstructured":"Bravo PE, Fujikura K, Kijewski MF et al (2019) Relative apical sparing of myocardial longitudinal strain is explained by regional differences in total amyloid mass rather than the proportion of amyloid deposits. JACC Cardiovasc Imaging 12(7 Pt 1):1165\u20131173","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"2348_CR26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1161\/CIRCIMAGING.112.976738","volume":"5","author":"S Dass","year":"2012","unstructured":"Dass S, Suttie JJ, Piechnik SK et al (2012) Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 5(6):726\u2013733","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"2348_CR27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/RLI.0b013e318059e021","volume":"42","author":"W Hosch","year":"2007","unstructured":"Hosch W, Bock M, Libicher M et al (2007) MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis. Invest Radiol 42(9):636\u2013642","journal-title":"Invest Radiol"},{"issue":"2","key":"2348_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","volume":"7","author":"M Fontana","year":"2014","unstructured":"Fontana M, Banypersad SM, Treibel TA et al (2014) Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 7(2):157\u2013165","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"2348_CR29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00392-022-02005-2","volume":"112","author":"D Lavall","year":"2023","unstructured":"Lavall D, Vosshage NH, Gessner R et al (2023) Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy. Clin Res Cardiol 112(3):334\u2013342","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"2348_CR30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","volume":"6","author":"TD Karamitsos","year":"2013","unstructured":"Karamitsos TD, Piechnik SK, Banypersad SM et al (2013) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 6(4):488\u2013497","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"2348_CR31","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/jmri.27459","volume":"53","author":"TKM Wang","year":"2021","unstructured":"Wang TKM, Brizneda MV, Kwon DH et al (2021) Reference ranges, diagnostic and prognostic utility of native T1 mapping and extracellular volume for cardiac amyloidosis: a meta-analysis. J Magn Reson Imaging 53(5):1458\u20131468","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"2348_CR32","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","volume":"13","author":"JA Pan","year":"2020","unstructured":"Pan JA, Kerwin MJ, Salerno M (2020) Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis. JACC Cardiovasc Imaging 13(6):1299\u20131310","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"2348_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10554-019-01717-3","volume":"36","author":"HQ Vo","year":"2020","unstructured":"Vo HQ, Marwick TH, Negishi K (2020) Pooled summary of native T1 value and extracellular volume with MOLLI variant sequences in normal subjects and patients with cardiovascular disease. Int J Cardiovasc Imaging 36(2):325\u2013336","journal-title":"Int J Cardiovasc Imaging"},{"issue":"6","key":"2348_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41569-022-00682-0","volume":"19","author":"SJ Lehman","year":"2022","unstructured":"Lehman SJ, Crocini C, Leinwand LA (2022) Targeting the sarcomere in inherited cardiomyopathies. Nat Rev Cardiol 19(6):353\u2013363","journal-title":"Nat Rev Cardiol"},{"key":"2348_CR35","doi-asserted-by":"crossref","unstructured":"de Boer RA, Heymans S, Backs J, et al. (2022) Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC). Eur J Heart Fail 24(3): 406\u201320.","DOI":"10.1002\/ejhf.2414"},{"issue":"11","key":"2348_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007\u20131016","journal-title":"N Engl J Med"},{"issue":"9","key":"2348_CR37","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/ejhf.2589","volume":"24","author":"AS Antonopoulos","year":"2022","unstructured":"Antonopoulos AS, Panagiotopoulos I, Kouroutzoglou A et al (2022) Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta-analysis. Eur J Heart Fail 24(9):1677\u20131696","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"2348_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jaccao.2021.09.003","volume":"3","author":"G Bianchi","year":"2021","unstructured":"Bianchi G, Zhang Y, Comenzo RL (2021) AL amyloidosis: current chemotherapy and immune therapy treatment strategies: JACC: CardioOncology state-of-the-art review. JACC CardioOncol 3(4):467\u2013487","journal-title":"JACC CardioOncol"},{"issue":"3","key":"2348_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00392-022-02043-w","volume":"112","author":"P Martens","year":"2023","unstructured":"Martens P, Hanna M, Valent J, Estep JD, Tang WHW (2023) Supra-normal left ventricular ejection fraction in cardiac amyloidosis. Clin Res Cardiol 112(3):441\u2013443","journal-title":"Clin Res Cardiol"},{"key":"2348_CR40","doi-asserted-by":"crossref","unstructured":"Wheeler MT, Olivotto I, Elliott PM, et al. Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized Trial. JAMA Cardiol 2023.","DOI":"10.1001\/jamacardio.2022.5099"},{"issue":"1","key":"2348_CR41","doi-asserted-by":"publisher","first-page":"15521","DOI":"10.1038\/s41598-021-94650-2","volume":"11","author":"D Korthals","year":"2021","unstructured":"Korthals D, Chatzantonis G, Bietenbeck M, Meier C, Stalling P, Yilmaz A (2021) CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis. Sci Rep 11(1):15521","journal-title":"Sci Rep"},{"issue":"1 Pt 1","key":"2348_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jcmg.2019.04.006","volume":"13","author":"G Korosoglou","year":"2020","unstructured":"Korosoglou G, Giusca S (2020) Strain for stress testing: Is it a featuring or supporting role in cardiac magnetic resonance? JACC Cardiovasc Imaging 13(1 Pt 1):66\u201368","journal-title":"JACC Cardiovasc Imaging"},{"key":"2348_CR43","doi-asserted-by":"publisher","first-page":"1017097","DOI":"10.3389\/fcvm.2022.1017097","volume":"9","author":"X Yue","year":"2022","unstructured":"Yue X, Yang L, Wang R et al (2022) The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients. Front Cardiovasc Med 9:1017097","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"2348_CR44","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jcmg.2022.11.020","volume":"16","author":"G Korosoglou","year":"2023","unstructured":"Korosoglou G, Ochs M (2023) Spotlight on myocardial deformation in hypertrophic cardiomyopathy: Putting the puzzle together? JACC Cardiovasc Imaging 16(4):492\u2013494","journal-title":"JACC Cardiovasc Imaging"},{"key":"2348_CR45","doi-asserted-by":"crossref","unstructured":"Amr A, Koelemen J, Reich C, et al. (2023) Improving sudden cardiac death risk stratification in hypertrophic cardiomyopathy using established clinical variables and genetic information. Clin Res Cardiol.","DOI":"10.1007\/s00392-023-02310-4"},{"issue":"5","key":"2348_CR46","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCIMAGING.112.000627","volume":"6","author":"S Cheng","year":"2013","unstructured":"Cheng S, Larson MG, McCabe EL et al (2013) Age- and sex-based reference limits and clinical correlates of myocardial strain and synchrony: the Framingham Heart Study. Circ Cardiovasc Imaging 6(5):692\u2013699","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02348-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02348-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02348-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T09:05:27Z","timestamp":1708506327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02348-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["2348"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02348-4","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"10 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HS, GK and SK received research grants from Myocardial Solutions. SK and HS own stock options of Myocardial Solutions. All other authors declare that they have no competing interests regarding this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study was approved by Ethics Committee of the University of Hamburg (PV7193). All patients gave written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}